Investors

Announcements

2022

30 September 2022

Final Results for period to 29 March 2022

01 August 2022

Further re: FDA Update

01 July 2022

FDA Update

08 June 2022

Holding(s) in Company

31 May 2022

Fundraise, Issue of Warrants & Appointment of Broker and Financial Adviser

28 April 2022

US Reseller and Funding Agreement & Proposed Board Changes

04 January 2022

Result of AGM

2021

29 December 2021

Interim Results - for the six months ended 30 September 2021

02 November 2021

FDA Update

30 September 2021

Holding(s) in Company

30 September 2021

Final Results for period to 29 March 2021

20 September 2021

Fundraise & Issue of Warrants, FDA update and Appointment of Broker

23 July 2021

Holding(s) in Company

23 June 2021

Appointment of Vice President of Sales and Marketing

04 June 2021

Appointment of Director & Grant of Options

27 May 2021

Survey of Cervi-LOK™

25 May 2021

Further re Subscription

09 April 2021

Holding(s) in Company

07 April 2021

Further Subscription

06 April 2021

Subscription Default

01 April 2021

Subscription and Corporate Update

30 March 2021

Proposed Equity Fundraise

01 March 2021

Further re: Extension of Subscription Date

06 January 2021

Further re: Extension of Subscription Date

2020

31 December 2020

Interim Results for the six months ended 30 September 2020

24 December 2020

FDA approval and working capital

24 November 2020

Result of AGM

12 November 2020

Further re: Subscription Agreement

30 October 2020

Final Results for period to 29 March 2020

21 October 2020

Cervi-LOK™ test results

29 September 2020

Extension of Reporting Deadline

14 September 2020

Subscription and Advisory Agreement

20 August 2020

Admission to trading and first day of dealings